Purchases and Sales Made in Q2 2025 in Keros Therapeutics, Inc. (KROS)
This table provides information about the institutional ownership of Keros Therapeutics, Inc. (KROS) during Q2 2025. The information is specifically focused on institutions that hold shares of Keros Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Jul 11, 2025
Q2 2025
|
Assenagon Asset Management S.A.
|
BUY
|
- |
36.4K+ 55.99% |
$347K - $549K
|
101K
$1.36M
|